This website uses cookies

We use cookies to personalise content and ads, to provide social media features and to analyse our traffic. We also share information about your use of our site with our social media, advertising and analytics partners who may combine it with other information that you’ve provided to them or that they’ve collected from your use of their services.

Coronex small


Coronex is a collaboration of Scottish and UK based biotechnology industry partners working with NHS Greater Glasgow and Clyde clinical and biorepository teams on the development of highly optimised lateral flow tests. Whilst its primary focus was on COVID-19, the same core technology has applications for other infectious agents and may also be used for monitoring therapeutic antibodies used as drug treatments or in detecting autoantibodies in autoimmune disorders.

Coronex is a 2020 spin-out company of NHS Greater Glasgow and Clyde and InnoScot Health.

LF test visual

Coronex’s technological advancements optimise the mechanism by which antibodies are detected in the LF test, thereby minimising ambiguous or inaccurate results whilst also allowing the target antigen to be easily changed.

This means the test kits offer clearer, more accurate results, are easily altered to adapt to virus mutations and are cheaper to manufacture.

Point of care antibody tests using a ‘lateral flow’ mechanism require no specialist equipment and can be done anywhere, producing results in between 10 – 20 minutes. The accuracy and specificity of such tests, and the ability to rapidly adapt to, and detect, viral mutations is vaulable.

Gillian Henderson 1

The unique lateral flow design has several innovative features that will produce a more accurate test than traditional designs and can be rapidly adapted to viral mutations.

Gillian Henderson, Head of Project Management, InnoScot Health

The platform technology developed by the Coronex team is readily adaptable to a wide range of disease areas where antibody testing is critical. This includes other infectious diseases and autoimmune diseases.

Partners in the Coronex collaboration are:

Homepage news carousel image opt

View our latest news

From innovation calls to new products or opinion pieces, read all the latest news and updates from InnoScot Health.

Homepage events carousel image

Check out the latest events

From exhibitions to webinars, stay up to date with the latest opportunities to meet with the InnoScot Health team.

Homepage themed calls carousel image opt

Latest innovation calls

A package of support is available from InnoScot Health for ideas relating to areas of priority need.


© Copyright 2024, InnoScot Health.

All rights reserved.

InnoScot Health works in partnership with NHS Scotland to identify, protect, develop and commercialise new innovations from healthcare professionals. Registered Number: SC 236303. Registered address: 272 Bath Street, Glasgow, G2 4JR
Office Address / Deliveries: Suite 203, The Pentagon Centre, 36 Washington Street, Glasgow, G3 8AZ